-+ 0.00%
-+ 0.00%
-+ 0.00%

According to media reports, citing people familiar with the matter, Eli Lilly is in negotiations to acquire psychedelic drug manufacturer AtaiBeckley, and the deal may be announced as early as this week. AtaiBeckley shares soared 66% in after-hours trading, while Eli Lilly's shares remained flat. According to the data, AtaiBeckley has accumulated a cumulative increase of 31% so far this year, with a market capitalization of 1.97 billion US dollars as of Wednesday's close. The report said that Eli Lilly is in negotiations at a premium.

Zhitongcaijing·07/15/2026 23:33:06
Listen to the news
According to media reports, citing people familiar with the matter, Eli Lilly is in negotiations to acquire psychedelic drug manufacturer AtaiBeckley, and the deal may be announced as early as this week. AtaiBeckley shares soared 66% in after-hours trading, while Eli Lilly's shares remained flat. According to the data, AtaiBeckley has accumulated a cumulative increase of 31% so far this year, with a market capitalization of 1.97 billion US dollars as of Wednesday's close. The report said that Eli Lilly is in negotiations at a premium.